BaseSpace
Import Your Data
QuickView

FAQ

More QuickView FAQs

Back to top
Clear Search sequence regions
(e.g. rs7903146, SLC12A1, G-protein-coupled receptor binding, Pseudomonas infection)
Bookmark Forward

QuickView for GPRC5D (gene)


Body Atlas

Most Correlated Tissues

  1. Superior cervical ganglion
  2. Plasma cell of spleen
  3. Skeletal muscle psoas
  4. Appendix
  5. Testis seminiferous tubule
Explore Body Atlas Results

Disease Atlas

Most Correlated Diseases

  1. Alopecia
  2. Wound of skin
  3. Zinc deficiency
  4. Lamellar ichthyosis
  5. Lupus erythematosus
Explore Disease Atlas Results

Pharmaco Atlas

Most Correlated Compounds

  1. Influenza A (H1N1) 2009 Monovalent Vaccine
  2. Fluvirin
  3. shikonin
  4. Pneumovax
  5. bifemelane
Explore Pharmaco Atlas Results

Knockdown Atlas

Most Correlated Gene Perturbations

  1. MIR211
  2. MLEC
  3. IQGAP1
  4. ZNF112
  5. PVALEF
Explore Knockdown Atlas Results

Curated Studies

Most Correlated Studies

Loading...
Explore Curated Studies Results

Literature

Most Relevant Literature

  1. Targeting GPRC5D in multiple myeloma.
  2. Targeting GPRC5D for multiple myeloma therapy.
  3. Research progress in targeting GPRC5D for the treatment of multiple myeloma].
  4. A novel T cell-redirecting anti-GPRC5D × CD3 bispecific antibody with potent antitumor activity in m…
  5. GPRC5D as a novel target for the treatment of multiple myeloma: a narrative review.
Explore Literature Results

Clinical Trials

Most Relevant Clinical Trials

  1. A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
  2. A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia
  3. To Assess Safety, Tolerability, and Efficacy of Anti-GPRC5D-CD19-CAR-T in Relapsed/Refractory Multip…
  4. A Clinical Study to Evaluate the Safety and Efficacy of BCMA-GPRC5D CAR-T in Patients With Relapsed/…
  5. Safety and Efficacy of Anti-GPRC5D CAR-T Cells Therapy in the Treatment of r/r MM
Explore Clinical Trials Results
  • Copyright © 2024 Illumina Inc. All rights reserved.